Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD
Simon Wabitsch, Justin McCallen, Olena Kamenyeva, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 748-760
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 313
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Josep M. Llovet, Catherine E. Willoughby, Amit G. Singal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 487-503
Closed Access | Times Cited: 177
A researcher’s guide to preclinical mouse NASH models
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1632-1649
Closed Access | Times Cited: 101
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect
Lin Zhu, Kaiqing Yang, Zhe Ren, et al.
Translational Oncology (2024) Vol. 44, pp. 101945-101945
Open Access | Times Cited: 15
Identification of common ferroptosis-related genes in metabolic dysfunction-associated steatotic liver disease and atherosclerosis using the support vector machine-recursive feature elimination algorithm
Hua Deng, Xiaodong Wang, Zichen Shao, et al.
Minerva Biotechnology and Biomolecular Research (2025) Vol. 37, Iss. 1
Closed Access | Times Cited: 1
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
Keisuke Sawada, Hak‐Jae Chung, Samir Softic, et al.
Cell Metabolism (2023) Vol. 35, Iss. 11, pp. 1852-1871
Open Access | Times Cited: 34
GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis
Tianxing Chen, Meng Yao, Zhihang Zhou, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 7, pp. 1829-1848
Closed Access | Times Cited: 33
Progress of research on the role of active ingredients of Citri Reticulatae Pericarpium in liver injury
Shuhan Gao, Xiaojing Chen, Zhiqian Yu, et al.
Phytomedicine (2023) Vol. 115, pp. 154836-154836
Closed Access | Times Cited: 24
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 23
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019
Carolyn T. Bramante, Kenneth B. Beckman, Tanvi Mehta, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 2, pp. 354-363
Closed Access | Times Cited: 13
Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma
Jun Wen, Xiang Zhang, Chi Chun Wong, et al.
Gut (2024) Vol. 73, Iss. 12, pp. 2023-2036
Open Access | Times Cited: 12
Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
Xin Ding, Xu He, Bulang Tang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
Jesús Rivera‐Esteban, Sergio Muñoz, Mónica Higuera, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1774-1789.e8
Closed Access | Times Cited: 9
Translational research on drug development and biomarker discovery for hepatocellular carcinoma
Valerie Chew, Chien-Huai Chuang, Chiun Hsu
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 8
Induction of autophagy via the PI3K/Akt/mTOR signaling pathway by Pueraria flavonoids improves non-alcoholic fatty liver disease in obese mice
Chunbin Sun, Jin Zhang, Jiong Hou, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114005-114005
Open Access | Times Cited: 36
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti–PD‐1 sensitive tumor microenvironments
Daniel J. Zabransky, Ludmila Danilova, James M. Leatherman, et al.
Hepatology (2022) Vol. 77, Iss. 5, pp. 1566-1579
Open Access | Times Cited: 34
The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3161-3161
Open Access | Times Cited: 19
Inflammatory processes involved in NASH-related hepatocellular carcinoma
Stefania Cannito, Umberto Dianzani, Maurizio Parola, et al.
Bioscience Reports (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 17
Molecular mechanisms of action of metformin: latest advances and therapeutic implications
Hong Zhu, Zhenquan Jia, Yunbo Robert Li, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 2941-2951
Open Access | Times Cited: 17
Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma
Han Wang, Allan Tsung, Lopa Mishra, et al.
EBioMedicine (2024) Vol. 101, pp. 105031-105031
Open Access | Times Cited: 7
The Gut Microbiome Controls Liver Tumors via the Vagus Nerve
Kylynda C. Bauer, Rajiv Trehan, Benjamin Ruf, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review
Fereshtehsadat Jalali, Fatemeh Fakhari, Afrah Sepehr, et al.
Translational Oncology (2024) Vol. 45, pp. 101946-101946
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top